Welcome to our dedicated page for Nano Dimension news (Ticker: NNDM), a resource for investors and traders seeking the latest updates and insights on Nano Dimension stock.
Nano Dimension Ltd. reports news about digital manufacturing operations, product-line performance, financial results, and corporate portfolio actions. Company updates commonly reference Markforged, Essemtec, additive manufacturing, surface-mount technology, industrial inkjet printing, and the role of software and materials in its manufacturing systems.
Nano Dimension news also covers strategic alternatives, cost-management actions, shareholder meetings, ADS-related governance matters, and its transition from foreign private issuer reporting to U.S. domestic periodic reporting. Recent corporate updates have included product-line monetization, a limited-duration shareholder rights agreement, and annual meeting results.
Nano Dimension (Nasdaq:NNDM) provided more detail on its proposed business combination with Infinite Epigenetics, an operating epigenetic diagnostics business.
Infinite has a CLIA-certified methylation lab, a network of 7,500+ healthcare providers, over 120,000 epigenetic samples, 50+ peer-reviewed studies, and commercial revenue. The transaction would pivot Nano from 3D printing to AI-driven preventive health and diagnostics and, according to the company, values Nano at net cash plus a 20% premium through ownership in the combined entity. Nano expects to receive two board seats in the merged company, with any definitive agreement to be put to a shareholder vote.
Summary not available.
Nano Dimension (Nasdaq:NNDM) signed a non-binding term sheet to combine with Infinite Epigenetics, creating a publicly traded, AI-powered preventive health and diagnostics company targeting a $90B+ U.S. clinical diagnostics market.
The deal values Infinite Epigenetics at $890 million. Existing Nano shareholders are expected to hold a meaningful minority stake, based on a stated value reflecting a 20% premium to Nano’s estimated net cash at closing and a contingent value right on legacy assets. The combined company is expected to have over $400 million in cash and trade on Nasdaq as “IEAI,” with Infinite CEO Dr. Matthew Dawson leading.
Summary not available.
Nano Dimension (Nasdaq:NNDM) CEO David Stehlin outlined progress on a three-phase strategic plan to maximize long-term shareholder value.
Phase 1 cut standalone operating expenses ~22% year-over-year in Q1 2026. Phase 2 includes selling AME, Fabrica, and MarkForged product lines, while maintaining about $441.6 million in liquidity. Phase 3 will select a focused strategic path.
Nano Dimension (Nasdaq:NNDM) agreed to sell its wholly owned subsidiary MarkForged to Stratasys (Nasdaq:SSYS) in an all-cash deal valued at $42.5 million.
The sale, part of Phase 2 of Nano Dimension’s three phase strategic plan, is expected to reduce annualized cash burn by about $15 million. Nano will retain the Markforged Metal Binder Jetting product line. Closing is targeted for the second half of 2026, subject to customary conditions and regulatory approvals.
Summary not available.
Nano Dimension (Nasdaq:NNDM) issued a letter to shareholders addressing Murchinson’s amended Schedule 13D filing and updating on its strategic alternatives review. The Board opposes Murchinson’s bid to replace three of five directors and gain effective control without a control premium, emphasizing its own ongoing process to maximize value for all shareholders.
Nano Dimension (Nasdaq: NNDM) reported Q1 2026 results and announced strategic actions to reduce cash burn and monetize product lines. Q1 revenue was $29.7M (+106% YoY); gross margin 40.8%; adjusted EBITDA loss $12.5M; net loss $69.7M including a $40.4M impairment. Cash and equivalents were $441.6M as of March 31, 2026. The company completed the sale of AME and Fabrica for up to $12.5M, expects ~$10M annualized cash-burn reduction, and suspended full-year 2026 guidance while evaluating strategic alternatives.
Nano Dimension (Nasdaq: NNDM) will host a conference call and webcast to discuss its Q1 2026 financial results for the period ended March 31, 2026. The call is scheduled for Thursday, May 7, 2026 at 4:30 PM ET.
Participants can pre-register to receive dial-in details, join via listed U.S., international, or Israel numbers, or listen via the live webcast and replay at the provided webcast URL. Attendees are advised to log in at least 10 minutes early.